We demonstrated the important role of ALOX12–12-HETE-GPR31 in HCC recurrence, which may provide a potential therapeutic target to reduce the tumor recurrence in NAFLD after liver transplantation. The gene discussed is GPR31; the disease is hepatocellular carcinoma.